Hisham Mehanna

Hisham Mehanna

University of Birmingham

H-index: 57

Europe-United Kingdom

About Hisham Mehanna

Hisham Mehanna, With an exceptional h-index of 57 and a recent h-index of 42 (since 2020), a distinguished researcher at University of Birmingham, specializes in the field of head neck cancer, thyroid cancer, Human Papillomavirus, clinical trials, biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Patient initiated follow-up in head and neck cancer

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial

Clinical trial endpoint use and definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: HNCIG international consensus recommendations.

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the …

Advances in testing for human papillomavirus-mediated head and neck cancer

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: HNCIG international consensus recommendations.

Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design

Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database

Hisham Mehanna Information

University

Position

Director and Professor Institute of head and Neck Studies and Education

Citations(all)

13031

Citations(since 2020)

8049

Cited By

8123

hIndex(all)

57

hIndex(since 2020)

42

i10Index(all)

134

i10Index(since 2020)

112

Email

University Profile Page

University of Birmingham

Google Scholar

View Google Scholar Profile

Hisham Mehanna Skills & Research Interests

head neck cancer

thyroid cancer

Human Papillomavirus

clinical trials

biomarkers

Top articles of Hisham Mehanna

Title

Journal

Author(s)

Publication Date

Patient initiated follow-up in head and neck cancer

Paul Nankivell

Hisham Mehanna

2024/4/1

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial

BMC Medical Research Methodology

Amit Patel

Kristian Brock

Daniel Slade

Claire Gaunt

Anthony Kong

...

2024/1/13

Clinical trial endpoint use and definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: HNCIG international consensus recommendations.

The Lancet Oncology

Annette M Lim

Lachlan McDowell

Chris Hurt

Christophe Le Tourneau

Akihiro Homma

...

2024/1/26

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the …

Robert L Ferris

Hisham Mohamed Mehanna

Jonathan Daniel Schoenfeld

Makoto Tahara

Sue S Yom

...

2023/6/1

Advances in testing for human papillomavirus-mediated head and neck cancer

Hisham Mehanna

Laia Alemany

Christian von Buchwald

2024/5/1

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: HNCIG international consensus recommendations.

The Lancet Oncology

Annette Lim

Sarbani Laskar

Conor Steuer

Velda Ling Yu Chow

Petr Szturz

...

2024/1/26

Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design

Robert L Ferris

Hisham Mehanna

Jonathan D Schoenfeld

Makoto Tahara

Sue S Yom

...

2023/12

Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database

European Journal of Cancer

Sujith Baliga

Ahmad K Abou-Foul

Pablo Parente

Petr Szturz

Juliette Thariat

...

2024/5/1

Criteria for the diagnosis of extra nodal extension detected on radiological imaging in head and neck cancer: HNCIG international consensus recommendations

The Lancet Oncology

Hisham Mehanna

Ahmad Abou-Foul

Paul Nankivell

2024/1/26

Prognostic Biomarkers for Malignant Progression of Oral Epithelial Dysplasia: An Updated Systematic Review and Meta-Analysis

Natalie Turton

Karl Payne

James Higginson

Prav Praveen

Hisham Mehanna

...

2024/3/7

Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo …

Florent Carsuzaa

Emilien Chabrillac

Pierre Yves Marcy

Hisham Mehanna

Juliette Thariat

2024/4/10

Developing and validating a multivariable prognostic-predictive classifier for treatment escalation of oropharyngeal squamous cell carcinoma: the PREDICTR-OPC study

Clinical Cancer Research

Hisham Mehanna

Davy Rapozo

Sandra V von Zeidler

Kevin J Harrington

Stuart C Winter

...

2024/1/17

Development of the ‘ACT now & check-it-out’intervention to support patient-initiated follow up for Head and Neck cancer patients

Patient Education and Counseling

Lauren Matheson

Colin Greaves

Joan L Duda

Mary Wells

Denis Secher

...

2024/2/1

Circulating tumour DNA detects somatic variants contributing to spatial and temporal intratumoural heterogeneity in head and neck squamous cell carcinoma

Frontiers in Oncology

Karl F Payne

Peter Brotherwood

Harini Suriyanarayanan

Jill Brooks

Nikolaos Batis

...

2024/4/9

CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal …

Trials

Hisham Mehanna

Piers Gaunt

Anthony Kong

Andrew Hartley

Paul Sanghera

...

2024/1/15

Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre-or post-operatively in head and neck cancer

BJC Reports

Anthony Kong

Amanda J Kirkham

Joshua S Savage

Rhys Mant

Siân Lax

...

2024/1/29

Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis

The Lancet Oncology

Hisham Mehanna

Miren Taberna

Christian Von Buchwald

Sara Tous

Jill Brooks

...

2023/3/1

Patient preference for commonly‐used, head and neck cancer‐specific quality of life questionnaires in the follow‐up setting (Determin): A multi‐centre randomised controlled …

Clinical Otolaryngology

Hisham Mehanna

Ben Carter

Andrew Hartley

Ahmad K Abou‐Foul

Jill Brooks

...

2023/7

A systematic review of the effectiveness of patient‐initiated follow‐up after cancer

Janine Dretzke

Talhah Chaudri

Rishab Balaji

Hisham Mehanna

Paul Nankivell

...

2023/9

Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia

British Journal of Cancer

Hanya Mahmood

Adam Shephard

Paul Hankinson

Mike Bradburn

Anna Luiza Damaceno Araujo

...

2023/11/9

See List of Professors in Hisham Mehanna University(University of Birmingham)

Co-Authors

H-index: 110
Robert L. Ferris

Robert L. Ferris

University of Pittsburgh

H-index: 105
Quynh-Thu Le

Quynh-Thu Le

Stanford University

H-index: 45
Claire Hulme

Claire Hulme

University of Exeter

H-index: 44
Michael Drinnan

Michael Drinnan

Newcastle University

H-index: 41
Gabriel Landini

Gabriel Landini

University of Birmingham

H-index: 29
Paul Nankivell

Paul Nankivell

University of Birmingham

academic-engine